Insulin sensitizing and α-glucoamylase inhibitory action of sennosides, rheins and rhaponticin in Rhei Rhizoma

Life Sciences

Volumn 78, Issue 9, 2006, Pages 934-942

  Choi, Soo Bong ^a   Ko, Byoung Seob ^b   Park, Seong Kyu ^c   Jang, Jin Sun ^d   Park, Sunmin ^d  

^a Konkuk University   (South Korea)

^b Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^c Kyung Hee University   (South Korea)

^d Hoseo University   (South Korea)

Author keywords

3T3 L1 adipocytes; Glucose tolerance; Insulin secretion; Insulin sensitivity; Min6 cells

Indexed keywords

ACARBOSE; ALCOHOL; GLUCAN 1,4 ALPHA GLUCOSIDASE; GLUCOSE; PIOGLITAZONE; RHAPONTIN; RHEIN; RHUBARB EXTRACT; SENNOSIDE A; SENNOSIDE B; STREPTOZOCIN; TRIACYLGLYCEROL;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; IN VITRO STUDY; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; MOUSE; NONHUMAN; STREPTOZOCIN DIABETES;

ADIPOCYTES; ANIMALS; ANTHRAQUINONES; BLOOD PRESSURE; BODY WEIGHT; CELL DIFFERENTIATION; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; ETHANOL; FIBROBLASTS; GLUCAN 1,4-ALPHA-GLUCOSIDASE; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; PLANT EXTRACTS; SOLVENTS; STILBENES; TRIGLYCERIDES;

ANIMALIA; RHEUM X HYBRIDUM;

EID: 30944468918     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.05.101     Document Type: Article

References (30)

1. B. Ahren, and G. Pacini Islet adaptation to insulin resistance: mechanisms and implications for intervention Diabetes and Obesity Metabolism 7 2005 2 8
2. J. Berger, P. Bailey, C. Biswas, C.A. Cullinan, T.W. Doebber, N.S. Hoyes, R. Saperstein, R.G. Smith, and M.D. Leibowitz Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: binding and activation correlate with antidiabetic actions in db/db mice Endocrinology 137 1996 4189 4195
3. A.M. Chang, M.J. Smith, C.J. Bloem, A.T. Galecki, and J.B. Halter Effect of lowering postprandial hyperglycemia on insulin secretion in older people with impaired glucose tolerance American Journal of Physiology Endocrinology Metabolism 287 2004 E906 E911
4. J.L. Chiasson, and R. Rabasa-Lhoret Prevention of type 2 diabetes: insulin resistance and beta-cell function Diabetes 53 2004 S34 S38
5. S.B. Choi, D.W. Jun, and S. Park The insulin sensitizing effect of homoisoflavone-enriched fraction in Liriope platyphylla Wang et Tang via PI3-kinase pathway Life Science 75 2004 2653 2664
6. Committee of SAS Institute Guide for Personal Computers 1985 SAS Institutes Inc Cary NC 257 260
7. T. Fujiwara, S. Yoshioka, and T. Yoshioka Characterization of a new oral antidiabetic agent CS-045: studies in KK and ob/ob mice and Zucker fatty rats Diabetes 37 1988 1549 1558
8. H. Goto, Y. Shimada, K. Tanikawa, S. Sato, H. Hikiami, N. Sekiya, and K. Terasawa Clinical evaluation of the effect of daio (rhei Rhei rhizomaRhizoma) on the progression of diabetic nephropathy with overt proteinuria American Journal of Chinese Medicine 31 2003 267 275
9. S. Hallakou, L. Doare, F. Foufelle, M. Kergoat, M. Guerre-Millo, M.F. Berthault, I. Dugail, J. Morin, J. Auwerx, and P. Ferre Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat Diabetes 46 1997 1393 1399
10. K. Inukai, M. Watanabe, Y. Nakashima, N. Takata, A. Isoyama, T. Sawa, S. Kurihara, T. Awata, and S. Katayama Glimepiride enhances intrinsic peroxisome proliferator-activated receptor-γ activity in 3T3-L1 adipocytes Biochemical and Biophysical Research Communications 328 2005 484 490
11. M. Iwanishi, and M. Kobayashi Effect of pioglitazone on insulin receptors of skeletal muscles from high-fat-fed rats Metabolism 42 1993 1017 1021
12. S.E. Kahn The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes Diabetologia 46 2003 3 19
13. M.W. Kim, S.Y. Chang, J.H. Lee, S.K. Ko, and C.S. Yook Studies on determination of sennoside A and sennoside B in Rheum spp. Bulletin Kyung Hee Pharmacological Science 28 2000 115 120
14. Y.S. Kim, E.A. Jung, J.E. Shin, J.C. Chang, H.K. Yang, N.J. Kim, K.H. Cho, H.S. Bae, S.K. Moon, and D.H. Kim Daio-Orengedokuto inhibits HMG-CoA reductase and pancreatic lipase Biological Pharmacology Bulletin 25 2002 1442 1445
15. T. Kiso, K. Hamayasu, K. Fujita, K. Hara, S. Kitahata, and H. Nakano Inhibition of beta-fructofuranosidases and alpha-glucosidases by synthetic thio-fructofuranoside Bioscience, Biotechnology, and Biochemistry 67 2003 1719 1724
16. M. Korytkowski, A. Thomas, L. Reid, M.B. Tedesco, W.E. Gooding, and J. Gerich Glimepiride improves both first and second phases of insulin secretion in type 2 diabetes Diabetes Care 25 2002 1607 1611
17. T. Matsui, M. Kobayashi, S. Hayashida, and K. Matsumoto Luteolin, a flavone, does not suppress postprandial glucose absorption through an inhibition of alpha-glucosidase action Bioscience, Biotechnology, and Biochemistry 66 2002 689 692
18. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man Diabetologia 28 1985 412 419
19. Y. Miyazaki, A. Mahankali, E. Wajcberg, M. Bajaj, L.J. Mandarino, and R.A. DeFronzo Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients Journal of Clinical Endocrinology Metabolism 89 2004 4312 4319
20. J.J. Nolan, B. Ludvik, and P. Beerdsen Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone New England Journal of Medicine 331 1994 1188 1193
21. A. Okuno, H. Tamemoto, K. Tobe, K. Ueki, Y. Mori, K. Iwamoto, K. Umesono, Y. Akanuma, T. Fujiwara, H. Horikoshi, Y. Yazaki, and T. Kadowaki Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats Journal of Clinical Investigation 101 1998 1354 1361
22. K. Osei, T. Gaillard, J. Kaplow, M. Bullock, and D. Schuster Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes Metabolism 53 2004 1552 1557
23. E.K. Park, M.K. Choo, H.K. Yoon, and D.H. Kim Antithrombotic and antiallergic activities of rhaponticin from Rhei Rhizoma are activated by human intestinal bacteria Archives of Pharmacology Research 25 2002 528 533
24. G. Perseghin, A. Caumo, C. Arcelloni, S. Benedini, R. Lanzi, E. Pagliato, L.P. Sereni, G. Testolin, A. Battezzati, G. Comi, M. Comola, and L. Luzi Contribution of abnormal insulin secretion and insulin resistance to the pathogenesis of type 2 diabetes in myotonic dystrophy Diabetes Care 26 2003 2112 2118
25. K. Sagara, T. Oshima, and T. Yoshida Rapid and simple determination of sennosides A and B in Rhei Rhizoma by ion-pair high-performance liquid chromatography Journal of Chromatography 403 1987 253 261
26. M. Schupp, J. Janke, R. Clasen, T. Unger, and U. Kintscher Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-γ activity Circulation 109 2004 2054 2057
27. A. Shimaya, K.S. Kovacina, and R.A. Roth On the mechanism for neomycin reversal of wortmannin inhibition of insulin stimulation of glucose uptake Journal of Biological Chemistry 279 2004 55277 55282
28. Y. Takizawa, T. Morota, S. Takeda, and M. Aburada Pharmacokinetics of rhein from Onpi-to, an Oriental herbal medicine, in rats Biological & Pharmaceutical Bulletin 26 2003 613 617
29. U.F. Wehmeier, and W. Piepersberg Biotechnology and molecular biology of the alpha-glucosidase inhibitor acarbose Applied Microbiology and Biotechnology 63 2004 613 625
30. G.C. Weir, and S. Bonner-Weir Five stages of evolving beta-cell dysfunction during progression to diabetes Diabetes 53 2004 S16 S21